---
figid: PMC9182524__molecules-27-03412-g003
pmcid: PMC9182524
image_filename: molecules-27-03412-g003.jpg
figure_link: /pmc/articles/PMC9182524/figure/molecules-27-03412-f003/
number: Figure 3
figure_title: ''
caption: 'The schematic representation of the PI3K/Akt/mTOR signaling pathway in BC.
  VEGF: vascular endothelial growth factor; NF-ÎºB: nuclear factor kappa-B; EGF(R):
  epidermal growth factor (receptor); mTOR: mammalian target of rapamycin; PDK1/2:
  3-phosphoinositide-dependent kinase-1/2; PI3K: phosphatidylinositol 3-kinase; MMP:
  matrix metalloprotein; PIP-3: phosphatidylinositol (3,4,5)-trisphosphate; Bcl-2:
  B-cell lymphoma 2; mTORC-2: mTOR complex 2; VRGF: vascular endothelial growth factor;
  Bad: Bcl-2 antagonist of cell death. This figure is reproduced from Dong et al.
  [] (Creative Commons Attribution License (CC BY 4.0)).'
article_title: A Review of Twenty Years of Research on the Regulation of Signaling
  Pathways by Natural Products in Breast Cancer.
citation: Muhammad Naeem, et al. Molecules. 2022 Jun;27(11):3412.
year: '2022'

doi: 10.3390/molecules27113412
journal_title: Molecules
journal_nlm_ta: Molecules
publisher_name: MDPI

keywords:
- breast cancer
- natural products
- transcription factors
- signaling pathways
- treatment
- therapeutic agents
- combination therapy

---
